Belviq, also known as Lorcaserin, is a drug used for weight loss. However, the Food and Drug Administration (FDA) withdrew Belviq from the market in 2020 due to concerns over its safe usage. The withdrawal from the market was after a major clinical trial of over five years proved that Belviq increases the danger of developing several types of cancer for its users. Belviq use has been associated with various types of cancer. Victims can visit www.lawsuits.com for legal guidance on possible compensation plans. This article discusses various cancers associated with Belviq usage.
1. Lung Cancer
Lung cancer is among the most common types of cancer patients using Belviq suffer from. Belviq is also associated with a higher risk of cardiovascular death when compared with the placebo in the clinical trial. Lung cancer is particularly close because usually the cancer is discovered in late stages, and this is dangerous because it is harder to treat. The tendency towards the rise in the rate of new cases of lung cancer led to doubts over the extended use of Belviq and its possible implication for this deadly disease.
2. Pancreatic Cancer
Other safety issues that are associated with Belviq include pancreatic cancer. The major problem with pancreatic cancer is that it is identified at terminal stages, a time when there are few things that the doctor can do. Unfortunately, pancreatic cancer is one of the most lethal forms of cancer because of its high mortality rate. A clinical trial revealed increased cases of pancreatic cancer among Belviq users, and that is why professionals take particular interest in the drug and carefully consider its safety and possible role in advancing pancreatic cancer.
3. Colorectal Cancer
Cardiovascular problems that stem from colon and rectal cancer are also higher among Belviq users. Colorectal cancer, when detected early, has a better prognosis. However, Belviq use creates fear about the effects of the drug on the gastrointestinal tracts. When left untreated, colorectal cancer can cause dangerous consequences, including patients suffering from bowel obstruction, the spread of cancer cells to other organs, and the subsequent drop in the quality of life.
4. Breast Cancer
Breast cancer is predominant in women, though men can also develop the disease. Breast cancer can manifest as lumps in the breast, a change in size or shape of the breasts, or develop skin indentations. Breast cancer is caused by numerous things, such as genes and life choices, but due to the connection with Belviq, some patients and doctors might feel that their diagnosis is connected to past medications.
Implications for Belviq Users
For anyone that has taken Belviq and knows that they have been exposed to cancer-causing Belviq, this is a real life-changing moment. Apart from the psychological and physical bearing of a cancer diagnosis, the victims may also pursue legal claims.
These lawsuits claim that if the patients had known of the risks, they would have chosen other methods of weight loss. The legal bases, which are founded on failure to warn, negligence, and product liability, stress the obligation of manufacturers, especially pharmaceutical companies, to uphold patients’ safety over their revenue.
Conclusion
The connection between Belviq and all sorts of cancers has been a significant blow to the lives of many users. Although the drug promised to help people lose weight, the subsequent revelation of higher cancer risks has provoked upset and litigation. Users of Belviq need to be on the lookout for signs of pancreatic, colorectal, lung, breast, or possibly other types of cancer. Visiting a doctor and a lawyer for consultation can be critical to understanding their health and legal positions in case they become a victim of the drug.
